Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.52 |
| ▸ | AR | P10275 | 1/20 | 0.48 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.45 |
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | JAK3 | P52333 | 1/20 | 0.41 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.40 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31421008 | 0.94 | GPR119 (0.51) | GPR119ARRIPK1SCD5 | |
| SCHEMBL28070953 | 0.92 | GPR119 (0.50) | GPR119ARRIPK1JAK2JAK3 | |
| SCHEMBL30281088 | 0.91 | GPR119 (0.49) | GPR119ARRIPK1JAK2JAK3 | |
| SCHEMBL30280984 | 0.89 | GPR119 (0.47) | GPR119ARNSD2JAK2JAK3 | |
| SCHEMBL30280998 | 0.89 | GPR119 (0.47) | GPR119ARRIPK1NSD2JAK2 | |
| SCHEMBL29148949 | 0.85 | GPR119 (0.44) | GPR119ARRIPK1JAK2JAK3 | |
| SCHEMBL24366138 | 0.85 | AR (0.47) | GPR119ARJAK2JAK3PTK2 | |
| SCHEMBL1674044 | 0.85 | GPR119 (0.51) | GPR119ARJAK2JAK3PTK2 | |
| SCHEMBL31470897 | 0.85 | GPR119 (0.46) | GPR119ARJAK2JAK3PTK2 | |
| SCHEMBL29082237 | 0.85 | AR (0.47) | GPR119ARJAK2JAK3PTK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3713936-B1 | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2021-10-20 | — | — | EP | disclosed |
| US-11147275-B2 | Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi | BASF SE (DE) | 2021-10-19 | — | — | US | disclosed |
| US-20200315177-A1 | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2020-10-08 | — | — | US | disclosed |
| EP-3713936-A1 | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2020-09-30 | — | — | EP | disclosed |
| WO-2019101511-A1 | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2019-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11147275-B2 | Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi | CYP51A1, ERG28, PAOX | GPR119 4416/4885AR 4153/4885RIPK1 2751/4885 |
| US-20200315177-A1 | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | CYP51A1, ERG28, PAOX | GPR119 4416/4885AR 4153/4885RIPK1 2751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.